MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
2.350
0.000
0.00%
After Hours: 2.990 +0.64 +27.22% 18:21 08/12 EDT
OPEN
2.600
PREV CLOSE
2.350
HIGH
2.600
LOW
2.190
VOLUME
412.39K
TURNOVER
--
52 WEEK HIGH
22.20
52 WEEK LOW
2.190
MARKET CAP
7.10M
P/E (TTM)
-0.3755
1D
5D
1M
3M
1Y
5Y
1D
Femasys completes $30 million private placement financing
TipRanks · 1d ago
Weekly Report: what happened at FEMY last week (0803-0807)?
Weekly Report · 2d ago
Femasys Enters $30 Mln Private Placement; Up To $90 Mln Potential Proceeds; Stock Down
NASDAQ · 3d ago
Femasys announces $30M private placement
TipRanks · 5d ago
Femasys Announces $30M Private Placement Led By New Investors And Members Of Management
Benzinga · 5d ago
Press Release: Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Dow Jones · 5d ago
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Barchart · 6d ago
Weekly Report: what happened at FEMY last week (0727-0731)?
Weekly Report · 08/03 09:25
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.